AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 288: E287-E291, 2005; doi:10.1152/ajpendo.00440.2004
0193-1849/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (29)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kintscher, U.
Right arrow Articles by Law, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kintscher, U.
Right arrow Articles by Law, R. E.

INVITED REVIEW

PPAR{gamma}-mediated insulin sensitization: the importance of fat versus muscle

Ulrich Kintscher1 and Ronald E. Law2

1Center for Cardiovascular Research, Institut für Pharmakologie und Toxikologie, Campus Charité-Mitte, Charité-Universitätsmedizin Berlin, Berlin, Germany; and 2Takeda Pharmaceuticals North America, Inc., Lincolnshire, Illinois

Peroxisome proliferator-activated receptor-{gamma} (PPAR{gamma}) is a nuclear hormone receptor that functions as a transcriptional regulator in a variety of tissues. PPAR{gamma} activation, e.g., through binding of the synthetic glitazones or thiazolidinediones (TZD), results in a marked improvement in type 2 diabetic patients of insulin and glucose parameters resulting from an improvement of whole body insulin sensitivity. The role of different metabolic tissues (fat, skeletal muscle, liver) in mediating PPAR{gamma} function in glucose and insulin homeostasis is still unclear. Recently, the function of PPAR{gamma} in adipose tissue and skeletal muscle has been intensively characterized by using targeted deletion of PPAR{gamma} in those tissues. In those studies, adipose PPAR{gamma} has been identified as an essential mediator for the maintainance of whole body insulin sensitivity. Two major mechanisms have been described. 1) Adipose PPAR{gamma} protects nonadipose tissue against excessive lipid overload and maintains normal organ function (liver, skeletal muscle); and 2) adipose PPAR{gamma} guarantees a balanced and adequate production of secretion from adipose tissue of adipocytokines such as adiponectin and leptin, which are important mediators of insulin action in peripheral tissues. In contrast to studies in adipose-specific PPAR{gamma}-deficient mice, the data in muscle-specific PPAR{gamma}–/– mice demonstrate that whole body insulin sensitivity is, at least in part, relying on an intact PPAR{gamma} system in skeletal muscle. Finally, these early and elegant studies using tissue-specific PPAR{gamma} knockout mouse models pinpoint adipose tissue as the major target of TZD-mediated improvement of hyperlipidemia and insulin sensitization.

peroxisome proliferator-activated receptor-{gamma}; diabetes; glitazone



Address for reprint requests and other correspondence: U. Kintscher, Center for Cardiovascular Research, Institut für Pharmakologie und Toxikologie, Campus Charité-Mitte, Charité-Universitätsmedizin Berlin, Hessische Str. 3/4, 10115 Berlin, Germany (E-mail: ulrich.kintscher{at}charite.de)




This article has been cited by other articles:


Home page
DiabetesHome page
K. Hojlund, D. Glintborg, N. R. Andersen, J. B. Birk, J. T. Treebak, C. Frosig, H. Beck-Nielsen, and J. F.P. Wojtaszewski
Impaired Insulin-Stimulated Phosphorylation of Akt and AS160 in Skeletal Muscle of Women With Polycystic Ovary Syndrome Is Reversed by Pioglitazone Treatment
Diabetes, February 1, 2008; 57(2): 357 - 366.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. Kos, A. L. Harte, S. James, D. R. Snead, J. P. O'Hare, P. G. McTernan, and S. Kumar
Secretion of neuropeptide Y in human adipose tissue and its role in maintenance of adipose tissue mass
Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1335 - E1340.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
W. Li, J. Tonelli, P. Kishore, R. Owen, E. Goodman, P. E. Scherer, and M. Hawkins
Insulin-sensitizing effects of thiazolidinediones are not linked to adiponectin receptor expression in human fat or muscle
Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1301 - E1307.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
S. Savas, I. W. Taylor, J. L. Wrana, and H. Ozcelik
Functional nonsynonymous single nucleotide polymorphisms from the TGF-{beta} protein interaction network
Physiol Genomics, April 24, 2007; 29(2): 109 - 117.
[Abstract] [Full Text] [PDF]


Home page
Poult. Sci.Home page
H. Zhou, C. M. Evock-Clover, J. P. McMurtry, C. M. Ashwell, and S. J. Lamont
Genome-Wide Linkage Analysis to Identify Chromosomal Regions Affecting Phenotypic Traits in the Chicken. IV. Metabolic Traits
Poult. Sci., February 1, 2007; 86(2): 267 - 276.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
G. K. Bandyopadhyay, J. G. Yu, J. Ofrecio, and J. M. Olefsky
Increased Malonyl-CoA Levels in Muscle From Obese and Type 2 Diabetic Subjects Lead to Decreased Fatty Acid Oxidation and Increased Lipogenesis; Thiazolidinedione Treatment Reverses These Defects.
Diabetes, August 1, 2006; 55(8): 2277 - 2285.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
B. Desvergne, L. Michalik, and W. Wahli
Transcriptional Regulation of Metabolism
Physiol Rev, April 1, 2006; 86(2): 465 - 514.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.